No Data
Longboard Pharmaceuticals Price Target Raised to $36.00/Share From $30.00 by B. Riley Securities
Longboard Pharmaceuticals Price Target Raised to $36.00/Share From $30.00 by B. Riley Securities
Longboard Pharmaceuticals Is Maintained at Buy by B. Riley Securities
Longboard Pharmaceuticals Is Maintained at Buy by B. Riley Securities
H.C. Wainwright Maintains Longboard Pharmaceuticals(LBPH.US) With Buy Rating, Maintains Target Price $60
H.C. Wainwright analyst Patrick Trucchio maintains $Longboard Pharmaceuticals(LBPH.US)$ with a buy rating, and maintains the target price at $60.According to TipRanks data, the analyst has a success r
B. Riley Raises Price Target on Longboard Pharmaceuticals to $36 From $30, Maintains Buy Rating
Longboard Pharmaceuticals (LBPH) has an average investment rating of buy among analysts polled by Capital IQ, with price targets ranging from $32 to $60.
Citi Maintains Longboard Pharmaceuticals(LBPH.US) With Buy Rating, Maintains Target Price $40
Citi analyst David Hoang maintains $Longboard Pharmaceuticals(LBPH.US)$ with a buy rating, and maintains the target price at $40.According to TipRanks data, the analyst has a success rate of 35.3% and
Express News | Longboard Pharmaceuticals Inc : B. Riley Raises Target Price to $36 From $30